1. Home
  2. NOTV vs ICCM Comparison

NOTV vs ICCM Comparison

Compare NOTV & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.82

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.68

Market Cap

45.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
ICCM
Founded
1974
2006
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
45.5M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NOTV
ICCM
Price
$0.82
$0.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$2.50
AVG Volume (30 Days)
1.6M
385.9K
Earning Date
12-03-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$2,975,000.00
Revenue This Year
$6.26
$13.67
Revenue Next Year
$45.49
$38.55
P/E Ratio
N/A
N/A
Revenue Growth
4.54
N/A
52 Week Low
$0.66
$0.59
52 Week High
$6.48
$1.66

Technical Indicators

Market Signals
Indicator
NOTV
ICCM
Relative Strength Index (RSI) 37.84 41.57
Support Level $0.79 $0.67
Resistance Level $0.95 $0.73
Average True Range (ATR) 0.09 0.04
MACD 0.01 0.01
Stochastic Oscillator 52.03 61.06

Price Performance

Historical Comparison
NOTV
ICCM

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: